Clinical trial NCT02720380: Buteyko Method for Children With Asthma
Official title: Buteyko Method for Children With Asthma: a Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Asthma
Child
Breathing Exercises
Keywords: Asthma
Physical Therapy Specialty
Breathing Exercises
Child
Clinical Trail
Lead sponsor: Universidade Federal do Rio Grande do Norte
Sponsor class: OTHER
First posted: 2016-03-25
Enrollment: 32
Sex: ALL
Minimum age (years): 7
Maximum age (years): 12
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study has the aim to assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of children with asthma.

Detailed description: Children from 7 to 12 years old with asthma diagnose will be included. Children in the intervention group will perform 6 sessions (twice a week) of treatment with the Buteyko Method. Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma. The investigators will assess quality of life by the PAQLQ (Paediatric Asthma Quality of Life Questionnaire), pulmonary function (spirometry) and the six-minute walk test. Vital signs, pulmonary auscultation and oxygen peripheral saturation will also be assessed during the tests. In addition, information will be collected on the numbers of hospitalizations, occurence of absence in school due to exacerbation of the disease, asthma symptoms and Beta2-agonists usage .

Eligibility criteria: Inclusion Criteria:

* Children from 7 up to 12 years old with asthma diagnose;
* Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks;
* Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.

Exclusion Criteria:

* Children that are not able to perform some of the necessary procedures;
* Give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Primary outcomes:
measure: Change in Quality of life (questionnaire)
timeFrame: Baseline and three weeks later
Secondary outcomes:
measure: Change in pulmonary function (spirometry)
timeFrame: Baseline and three weeks later
measure: Change in the Six-minute walk test distance
timeFrame: Baseline and three weeks later
measure: Number of visits to the emergency room
timeFrame: Through study completion, an average of three weeks
measure: Occurrence of absences in school
timeFrame: Through study completion, an average of three weeks
measure: Occurrence of exacerbations
timeFrame: Through study completion, an average of three weeks
measure: Occurrence of Beta2-agonists usage
timeFrame: Through study completion, an average of three weeks
Other outcomes:
Locations:
city: Natal
country: Brazil
facility: Universidade Federal do Rio Grande do Norte (UFRN)
state: Rio Grande do Norte
Study officials:
References: